SLC2A1 and malignant colon neoplasm: The GLUT1 inhibitor, BAY-876, might inhibit not only colon cancer cells but also other cells of the tumor microenvironment, like T cells, immune cells, cancer-associated fibroblasts, and endothelial cells.